Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Moniz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
EMBO Reports|October 31, 2014
Cezanne (OTUD7B) regulates HIF-1α homeostasis in a proteasome-independent mannerAnja Bremm, Sonia Moniz, Julia Mader, et al.
Journal of Cell Science|July 8, 2015
Cezanne regulates E2F1-dependent HIF2α expressionSonia Moniz, Daniel Bandarra, John Biddlestone, et al.
Cell Cycle (Georgetown, Tex.)|January 7, 2015
PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxiaSharon Mudie, Daniel Bandarra, Michael Batie, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2018
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition MetalsRichard J Wall, Sonia Moniz, Michael G Thomas, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' DiseaseMarta L Lima, Lindsay B Tulloch, Victoriano Corpas-Lopez, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
ACS Infectious Diseases|November 2, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovaniVictoriano Corpas-Lopez, Sonia Moniz, Michael Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
EMBO Reports|October 31, 2014
Cezanne (OTUD7B) regulates HIF-1α homeostasis in a proteasome-independent mannerAnja Bremm, Sonia Moniz, Julia Mader, et al.
Journal of Cell Science|July 8, 2015
Cezanne regulates E2F1-dependent HIF2α expressionSonia Moniz, Daniel Bandarra, John Biddlestone, et al.
Cell Cycle (Georgetown, Tex.)|January 7, 2015
PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxiaSharon Mudie, Daniel Bandarra, Michael Batie, et al.
Antimicrobial Agents and Chemotherapy|May 31, 2018
Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition MetalsRichard J Wall, Sonia Moniz, Michael G Thomas, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' DiseaseMarta L Lima, Lindsay B Tulloch, Victoriano Corpas-Lopez, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
ACS Infectious Diseases|November 2, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovaniVictoriano Corpas-Lopez, Sonia Moniz, Michael Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Pageof 1